# Oral Glycerol and High-Dose Rectal Paracetamol to Improve the Prognosis of Childhood Bacterial Meningitis

> **NCT00619203** · PHASE3 · COMPLETED · sponsor: **Kamuzu University of Health Sciences** · enrollment: 466 (actual)

## Conditions studied

- Bacterial Meningitis

## Interventions

- **DRUG:** Glycerol and paracetamol
- **DRUG:** Paracetamol
- **DRUG:** Paracetamol
- **DRUG:** Paracetamol
- **DRUG:** Placebo
- **DRUG:** Paracetamol and glycerol
- **DRUG:** Glycerol

## Key facts

- **NCT ID:** NCT00619203
- **Lead sponsor:** Kamuzu University of Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 466 (ACTUAL)
- **Last updated:** 2012-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00619203

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00619203, "Oral Glycerol and High-Dose Rectal Paracetamol to Improve the Prognosis of Childhood Bacterial Meningitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00619203. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*